PROGYNY, INC. (PGNY): Price and Financial Metrics


Today's Latest Price: $50.24 USD

2.96 (6.26%)

Updated Jan 22 4:15pm

Add PGNY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

PGNY Stock Summary

  • PGNY's went public 1.25 years ago, making it older than just 0.8% of listed US stocks we're tracking.
  • With a price/earnings ratio of 1,360.15, Progyny Inc P/E ratio is greater than that of about 99.07% of stocks in our set with positive earnings.
  • The ratio of debt to operating expenses for Progyny Inc is higher than it is for about merely 0.53% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Progyny Inc, a group of peers worth examining would be CDAY, FRPT, SGH, KAMN, and CELH.
  • PGNY's SEC filings can be seen here. And to visit Progyny Inc's official web site, go to

PGNY Stock Price Chart Interactive Chart >

Price chart for PGNY

PGNY Price/Volume Stats

Current price $50.24 52-week high $50.45
Prev. close $47.28 52-week low $15.59
Day low $46.64 Volume 755,000
Day high $50.45 Avg. volume 769,036
50-day MA $39.09 Dividend yield N/A
200-day MA $29.22 Market Cap 4.35B

PROGYNY, INC. (PGNY) Company Bio

Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

PGNY Latest News Stream

Event/Time News Detail
Loading, please wait...

PGNY Latest Social Stream

Loading social stream, please wait...

View Full PGNY Social Stream

Latest PGNY News From Around the Web

Below are the latest news stories about Progyny Inc that investors may wish to consider to help them evaluate PGNY as an investment opportunity.

Progyny, Inc. to Present at the 39th Annual JP Morgan Healthcare Conference

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family…

GlobeNewswire | January 5, 2021

In the midst of COVID, healthcare companies saw their stocks shoot up in 2020

In the midst of COVID, healthcare companies saw their stocks shoot up in 2020. Companies like Health Catalyst, Progyny and Guardant all saw big increases this year by Steven Loeb on December 29, 2020

VatorNews | December 29, 2020

Should We Be Cautious About Progyny, Inc.'s (NASDAQ:PGNY) ROE Of 2.5%?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Yahoo | December 24, 2020

Is PGNY A Good Stock To Buy Now?

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]

Yahoo | December 18, 2020

Progyny CEO on the future of fertility treatments amid COVID-19

Progyny CEO David Schlanger joins Yahoo Finance Live to discuss how his company has handled COVID-19, and the future of fertility treatments.

Yahoo | December 11, 2020

Read More 'PGNY' Stories Here

PGNY Price Returns

1-mo N/A
3-mo 88.24%
6-mo 91.76%
1-year 56.51%
3-year N/A
5-year N/A
YTD 18.52%
2020 54.43%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.762 seconds.